China Overseas Nuoxin International Holdings Limited (0464.HK)
HKD 0.34
(25.93%)
HKD 0.34
(25.93%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.02 Million HKD | 103.23% |
| 2022 | -41.99 Million HKD | -53.58% |
| 2021 | -7.48 Million HKD | -90.16% |
| 2020 | -19.45 Million HKD | 47.98% |
| 2019 | -33.52 Million HKD | 29.13% |
| 2018 | -50.61 Million HKD | -67.08% |
| 2017 | -31.63 Million HKD | -2685.25% |
| 2016 | -7.84 Million HKD | -76.95% |
| 2015 | -3.89 Million HKD | -64.58% |
| 2014 | 12.87 Million HKD | 143.47% |
| 2013 | -18.94 Million HKD | -162.57% |
| 2012 | 47.32 Million HKD | -21.72% |
| 2011 | 60.45 Million HKD | -35.52% |
| 2010 | 93.75 Million HKD | 15.45% |
| 2009 | 81.21 Million HKD | 4.31% |
| 2008 | 77.85 Million HKD | 102.2% |
| 2007 | 38.5 Million HKD | -39.84% |
| 2006 | 72.15 Million HKD | 183.35% |
| 2005 | 22.65 Million HKD | -66.09% |
| 2004 | 66.61 Million HKD | 52.97% |
| 2003 | 43.54 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | 6.66 Million HKD | 0.0% |
| 2023 FY | - HKD | 103.23% |
| 2023 Q2 | -6.03 Million HKD | 0.0% |
| 2022 FY | - HKD | -53.58% |
| 2022 Q2 | -16.9 Million HKD | 0.0% |
| 2022 Q4 | -34.21 Million HKD | 0.0% |
| 2021 FY | - HKD | -90.16% |
| 2021 Q2 | -14.29 Million HKD | 0.0% |
| 2021 Q4 | -18.67 Million HKD | 0.0% |
| 2020 Q2 | 1.81 Million HKD | 0.0% |
| 2020 FY | - HKD | 47.98% |
| 2020 Q4 | -14.75 Million HKD | 0.0% |
| 2019 Q4 | -20.34 Million HKD | 0.0% |
| 2019 FY | - HKD | 29.13% |
| 2019 Q2 | -11.83 Million HKD | 0.0% |
| 2018 FY | - HKD | -67.08% |
| 2018 Q2 | -26.98 Million HKD | 0.0% |
| 2018 Q4 | -18.41 Million HKD | 0.0% |
| 2017 Q2 | -7.87 Million HKD | 0.0% |
| 2017 FY | - HKD | -2685.25% |
| 2017 Q4 | -19.29 Million HKD | 0.0% |
| 2016 FY | - HKD | -76.95% |
| 2016 Q2 | -1.32 Million HKD | 0.0% |
| 2016 Q4 | 2.37 Million HKD | 0.0% |
| 2015 Q4 | 1.04 Million HKD | 0.0% |
| 2015 Q2 | 3.51 Million HKD | 0.0% |
| 2015 FY | - HKD | -64.58% |
| 2014 Q2 | 11.92 Million HKD | 0.0% |
| 2014 FY | - HKD | 143.47% |
| 2014 Q4 | 948 Thousand HKD | 0.0% |
| 2013 Q2 | 3.17 Million HKD | 0.0% |
| 2013 FY | - HKD | -162.57% |
| 2013 Q4 | -32.79 Million HKD | 0.0% |
| 2012 Q1 | 15.11 Million HKD | 0.0% |
| 2012 FY | - HKD | -21.72% |
| 2012 Q2 | 15.11 Million HKD | 0.0% |
| 2012 Q3 | 11.83 Million HKD | -21.72% |
| 2012 Q4 | 16.68 Million HKD | 41.02% |
| 2011 Q3 | 15.11 Million HKD | -35.52% |
| 2011 FY | - HKD | -35.52% |
| 2011 Q2 | 23.43 Million HKD | 0.0% |
| 2011 Q1 | 23.43 Million HKD | 0.0% |
| 2011 Q4 | 15.11 Million HKD | 0.0% |
| 2010 Q2 | 20.3 Million HKD | 0.0% |
| 2010 Q4 | 23.43 Million HKD | 0.0% |
| 2010 FY | - HKD | 15.45% |
| 2010 Q1 | 20.3 Million HKD | 0.0% |
| 2010 Q3 | 23.43 Million HKD | 15.45% |
| 2009 FY | - HKD | 4.31% |
| 2009 Q3 | 20.3 Million HKD | 4.31% |
| 2009 Q4 | 20.3 Million HKD | 0.0% |
| 2009 Q2 | 19.46 Million HKD | 0.0% |
| 2009 Q1 | 19.46 Million HKD | 0.0% |
| 2008 Q2 | 7.94 Million HKD | 0.0% |
| 2008 Q4 | 19.46 Million HKD | 0.0% |
| 2008 FY | - HKD | 102.2% |
| 2008 Q1 | 7.94 Million HKD | 0.0% |
| 2008 Q3 | 19.46 Million HKD | 145.08% |
| 2007 FY | - HKD | -39.84% |
| 2007 Q1 | 16.04 Million HKD | 0.0% |
| 2007 Q4 | 7.94 Million HKD | 0.0% |
| 2007 Q3 | 7.94 Million HKD | -50.5% |
| 2007 Q2 | 16.04 Million HKD | 0.0% |
| 2006 Q4 | 16.04 Million HKD | 0.0% |
| 2006 FY | - HKD | 183.35% |
| 2006 Q3 | 16.04 Million HKD | 280.64% |
| 2006 Q2 | 4.21 Million HKD | 0.0% |
| 2006 Q1 | 4.21 Million HKD | 0.0% |
| 2005 Q2 | 18.72 Million HKD | 0.0% |
| 2005 FY | - HKD | -66.09% |
| 2005 Q1 | 18.72 Million HKD | 0.0% |
| 2005 Q3 | 4.21 Million HKD | -77.5% |
| 2005 Q4 | 4.21 Million HKD | 0.0% |
| 2004 FY | - HKD | 52.97% |
| 2004 Q2 | 11.71 Million HKD | 0.0% |
| 2004 Q3 | 18.72 Million HKD | 59.89% |
| 2004 Q4 | 18.72 Million HKD | 0.0% |
| 2004 Q1 | 11.71 Million HKD | 0.0% |
| 2003 Q3 | 11.71 Million HKD | 0.0% |
| 2003 FY | - HKD | 0.0% |
| 2003 Q4 | 11.71 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | 91.144% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 99.361% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 110.307% |
| Huasheng International Holding Limited | 19.67 Million HKD | 89.689% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | 96.702% |
| Evergreen Products Group Limited | 140.78 Million HKD | 98.559% |
| EC Healthcare | 737.83 Million HKD | 99.725% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | 99.042% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 99.691% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 127.423% |
| Takbo Group Holdings Limited | 25.8 Million HKD | 92.137% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | 98.684% |